Cases 21 - 30 of 124
Boehringer Ingelheim Pharmaceuticals Inc. et al v. Hetero USA Inc. et al
as 1:2023cv00048
Plaintiff:
Boehringer Ingelheim Pharmaceuticals Inc., Boehringer Ingelheim International GmbH, Boehringer Ingelheim Corporation and others
Defendant:
Hetero USA Inc., Hetero Labs Limited Unit-V and Hetero Labs Limited
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
MERCK SHARP & DOHME LLC v. HETERO USA, INC. et al
as 2:2022cv06820
Plaintiff:
MERCK SHARP & DOHME LLC
Defendant:
HETERO USA, INC., HETERO LABS LIMITED UNIT-V and HETERO LABS LIMITED
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
AbbVie Inc. et al v. Alkem Laboratories Limited et al
as 1:2022cv01423
Plaintiff:
AbbVie Inc., AbbVie Ltd. and Neurocrine Biosciences, Inc.
Defendant:
Alkem Laboratories Limited, Hetero Labs Limited, Hetero Labs Limited Unit-V and others
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
AstraZeneca AB et al v. Annora Pharma Private Limited et al
as 1:2022cv01209
Plaintiff:
AstraZeneca AB and AstraZeneca Pharmaceuticals LP
Defendant:
Annora Pharma Private Limited, Hetero Labs Limited and Hetero USA, Inc.
Cause Of Action: 35 U.S.C. § 1 Patent Infringement
Aragon Pharmaceuticals, Inc. et al v. Hetero Labs Limited Unit V et al
as 1:2022cv00696
Plaintiff:
Aragon Pharmaceuticals, Inc., Janssen Biotech, Inc., The Regents of the University of California and others
Defendant:
Hetero Labs Limited Unit V and Hetero USA, Inc.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
ARAGON PHARMACEUTICALS, INC. et al v. HETERO LABS LIMITED UNIT V et al
as 2:2022cv03212
Plaintiff:
ARAGON PHARMACEUTICALS, INC., JANSSEN BIOTECH, INC., THE REGENTS OF THE UNIVERSITY OF CALIFORNIA and others
Defendant:
HETERO LABS LIMITED UNIT V and HETERO USA, INC.
Cause Of Action: 15 U.S.C. § 1126 Patent Infringement
THE ESTATE OF CONNIE KEEP v. AUROBINDO PHARMA, LTD. et al
as 1:2022cv02461
In Re:
VALSARTAN LOSARTAN AND IRBESARTAN PRODUCTS LIABILITY LITIGATION
Plaintiff:
CHARLES KEEP and THE ESTATE OF CONNIE KEEP
Defendant:
AUROBINDO PHARMA, LTD., TEVA PHARMACEUTICAL INDUSTRIES, LTD., ACTAVIS PHARMA INC. and others
Cause Of Action: 28 U.S.C. § 1332 Diversity-Product Liability
EISAI CO., LTD. et al v. HETERO USA INC. et al
as 1:2022cv01795
Plaintiff:
EISAI CO., LTD., EISAI INC. and NOVARTIS PHARMA AG
Defendant:
HETERO USA INC., HETERO LABS LIMITED and HETERO LABS LIMITED UNIT-III
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Merck Sharp & Dohme Corp. et al v. Hetero Labs Limited et al
as 1:2022cv00378
Plaintiff:
Merck Sharp & Dohme Corp., MSD International Business GmbH, MSD International GmbH and others
Defendant:
Hetero Labs Limited, Hetero Labs Limited Unit-V and Hetero USA Inc.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Novartis Pharmaceuticals Corporation v. Hetero USA Inc. et al
as 1:2021cv01760
Plaintiff:
Novartis Pharmaceuticals Corporation
Defendant:
Hetero USA Inc., Hetero Labs Limited and Hetero Labs Limited Unit III
Cause Of Action: 35 U.S.C. § 271
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
